Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07441525) titled 'UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Condition: Autoimmune Hemolytic Anemia Primary Immune Thrombocytopenic Purpura Evans Syndrome

Intervention: Drug: CART Infusion

Recruitment Status: Recruiting

Phase: Early Phase 1

Date of First Enrollment: February 3, 2026

Targe...